Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shai Shimony, M.D.

Concepts (136)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute20202435233.940 Why?
Trisomy220242661.590 Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma220244071.360 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma3202415191.100 Why?
Antibodies, Bispecific220231640.950 Why?
Sulfonamides6202419380.950 Why?
Staurosporine220212510.820 Why?
Lymphoma, T-Cell120242990.790 Why?
Hypertriglyceridemia120232930.730 Why?
Myelodysplastic Syndromes4202313520.730 Why?
Neutropenia220228950.690 Why?
Depsipeptides12019940.680 Why?
Lymphoma, T-Cell, Peripheral120191340.620 Why?
Gastritis120191960.600 Why?
Lymphoma, T-Cell, Cutaneous120192070.600 Why?
Antibiotics, Antineoplastic220236920.570 Why?
fms-Like Tyrosine Kinase 3520234910.570 Why?
Cytarabine320246920.570 Why?
Pyrazines1202212300.550 Why?
Neoplasms, Second Primary1202410610.540 Why?
Lymphoma1202318770.470 Why?
Leukemia, Lymphocytic, Chronic, B-Cell1202115960.360 Why?
Protein Kinase Inhibitors3202255350.350 Why?
Hematopoietic Stem Cell Transplantation4202154420.350 Why?
Echocardiography1201951020.280 Why?
Risk Assessment32023233380.270 Why?
Antineoplastic Combined Chemotherapy Protocols82024115240.260 Why?
Salvage Therapy2202212750.250 Why?
Humans4020247443430.240 Why?
Daunorubicin120241580.240 Why?
Kidney Transplantation1201942510.230 Why?
Prognosis62024290630.230 Why?
Antineoplastic Agents22024136950.230 Why?
Recurrence4202483400.220 Why?
Asparaginase120242360.210 Why?
Karyotyping1202412430.200 Why?
Disseminated Intravascular Coagulation120221880.200 Why?
Review Literature as Topic120233360.200 Why?
Retrospective Studies152024774490.190 Why?
Anemia, Aplastic120222260.180 Why?
Monoclonal Gammopathy of Undetermined Significance120221770.180 Why?
Chromosomes, Human, Pair 8120214600.180 Why?
Remission Induction3202123860.180 Why?
Azacitidine120213470.180 Why?
Paraproteinemias120222460.180 Why?
Glucose-6-Phosphate12019300.170 Why?
Proto-Oncogene Proteins p21(ras)2202416920.170 Why?
Lymphoma, Follicular120234350.170 Why?
Leukemia, Myeloid120227070.170 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma120202220.160 Why?
Retreatment120196100.160 Why?
Lymphoma, B-Cell, Marginal Zone120191800.150 Why?
Disease-Free Survival3202368950.150 Why?
Aniline Compounds120229860.150 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive120226890.150 Why?
Antigens, CD19120203800.150 Why?
Postoperative Complications12019152950.140 Why?
Antimetabolites, Antineoplastic120206400.140 Why?
Young Adult62024564300.130 Why?
Helicobacter pylori120193820.130 Why?
T-Lymphocytes22024101800.130 Why?
Helicobacter Infections120193860.130 Why?
Chromosome Aberrations1202118130.130 Why?
Thrombocytopenia1202211790.120 Why?
Pyridones120197120.120 Why?
Leukemia1202215110.120 Why?
Lymphoma, Large B-Cell, Diffuse1202313780.120 Why?
Methotrexate1202017270.110 Why?
Child52024777090.110 Why?
Combined Modality Therapy2202286420.110 Why?
Abdominal Pain1201910630.110 Why?
Bone Marrow1202329480.110 Why?
Ventricular Dysfunction, Left1202320730.100 Why?
Overweight1202323710.100 Why?
Kaplan-Meier Estimate2202065380.100 Why?
Antigens, Neoplasm1202019880.100 Why?
Mutation42023297860.100 Why?
Glomerular Filtration Rate1201921700.100 Why?
Ventricular Function, Left2202336700.090 Why?
Pulmonary Artery1201919120.090 Why?
Aged820231632800.090 Why?
Adolescent52024857810.090 Why?
Adult920232140550.090 Why?
Pyrazoles1201919720.080 Why?
C-Reactive Protein1202037780.080 Why?
Venous Thromboembolism1202116710.080 Why?
Hematologic Neoplasms1202018320.080 Why?
Middle Aged1020222133830.080 Why?
Acute Kidney Injury1202019720.080 Why?
Isocitrate Dehydrogenase220228710.070 Why?
Male920243501180.070 Why?
Body Mass Index12023127200.070 Why?
Drug Resistance, Neoplasm1201951720.060 Why?
Aged, 80 and over52020577760.060 Why?
Multiple Myeloma1202251810.060 Why?
Positron-Emission Tomography1201962340.050 Why?
Cohort Studies32023405610.050 Why?
Carcinoma, Non-Small-Cell Lung1202152210.050 Why?
Anthracyclines120232880.050 Why?
Obesity12023127450.050 Why?
Israel120237960.050 Why?
Follow-Up Studies22020390500.050 Why?
Atrial Fibrillation1201950340.050 Why?
Female720213801940.040 Why?
Antibody Specificity1202010950.040 Why?
Clinical Trials as Topic2202379130.040 Why?
Multicenter Studies as Topic1202216770.040 Why?
Lung Neoplasms12021131020.040 Why?
Treatment Outcome22020631140.030 Why?
Tomography, X-Ray Computed12019201290.030 Why?
Disease Susceptibility1202217820.030 Why?
Survival Rate22020127880.030 Why?
Neoplasm, Residual120209730.030 Why?
Anticoagulants2202145990.030 Why?
Transplantation Conditioning1202115980.030 Why?
Incidence22023209470.030 Why?
Hematopoiesis1202320720.030 Why?
Transplantation, Homologous1202147760.030 Why?
Enzyme Inhibitors1202237980.020 Why?
Gastrointestinal Diseases1202011700.020 Why?
Molecular Targeted Therapy1202327270.020 Why?
Stroke Volume1202350070.020 Why?
Hemorrhage1202234610.020 Why?
Epigenesis, Genetic1202336470.020 Why?
Cross-Sectional Studies22022250430.020 Why?
Nervous System Diseases1202016220.020 Why?
Immunotherapy1202344450.020 Why?
Longitudinal Studies12023139890.020 Why?
Prevalence12022152260.020 Why?
Cytokines1202073220.020 Why?
Pandemics1202383880.010 Why?
Predictive Value of Tests12019150760.010 Why?
Age Factors12019183700.010 Why?
Stroke1201999810.010 Why?
Prospective Studies12019532880.010 Why?
Risk Factors12020722900.010 Why?
Shimony's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (136)
Explore
_
Co-Authors (31)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.